In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...

Background: In Canada, many patients face substantial out-of-pocket costs for prescription medication, which may affect their ability to take their medications as prescribed. We sought to conduct a ...

Five Things to Know About ...: Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients with type 2 diabetes ...

La vaccination maternelle diminue les taux d’infection au VRS et d’admission à l’hôpital des nourrissons Dans le cadre d’un essai contrôlé randomisé, le vaccin VRSpréF a permis de prévenir 81,8 % ...

See related research at On Oct. 10, 2024, Bill C-64 — comprising the first concrete measures to implement universal, single-payer, public pharmacare in Canada — became law.[1][2] As an initial step ...

Access to health care: Emergency department use before cancer diagnosis in Ontario, Canada: a population-based study ...

Access to health care: Management of opioid use disorder: 2024 update to the national clinical practice guideline ...

Correction to “Advances in the management of renal cell carcinoma” ...

Background: Standard pharmacotherapy for patients with heart failure with reduced ejection fraction (HFrEF) comprises “quadruple therapy” with a renin–angiotensin system inhibitor, a β-blocker, a ...